Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Fish and Richardson
US Army
Argus Health
Cipla

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 10,179,135

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,179,135
Title:Apilimod compositions and methods for using same
Abstract: The present invention relates to methods for treating cancer with apilimod and related compositions and methods.
Inventor(s): Lichenstein; Henri (Guilford, CT), Rothberg; Jonathan M. (Guilford, CT), Gayle; Sophia (East Haven, CT), Beeharry; Neil (Guilford, CT), Beckett; Paul (Yorktown Heights, NY), Landrette; Sean (Meriden, CT), Conrad; Chris (Mount Vernon, NY), Dyer; Matt (Heber City, UT), Xu; Tian (Guilford, CT)
Assignee: LAM Therapeutics, Inc. (Guilford, CT)
Application Number:15/113,154
Patent Claims:see list of patent claims

Details for Patent 10,179,135

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up LAM Therapeutics, Inc. (Guilford, CT) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 10,179,135

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2015112888 Jul 30, 2015
World Intellectual Property Organization (WIPO) 2016073871 May 12, 2016
World Intellectual Property Organization (WIPO) 2016073877 May 12, 2016
World Intellectual Property Organization (WIPO) 2016073884 May 12, 2016
United States of America 2017007613 Jan 12, 2017
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Daiichi Sankyo
Merck
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.